S. 247 · 119th Congress · Health
Choices for Increased Mobility Act of 2025
- IntroducedJan 24, 2025 Done
- CommitteeReferred to Finance Current stage
- Senate floorNot yet Not reached yet
- House floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish specific billing codes under Medicare for certain materials used in ultralightweight manual wheelchairs.
Specifically, the CMS must establish at least two billing codes for the base of the wheelchair, with at least one code for a base with titanium or carbon fiber construction material and at least one code for a base without these materials. Suppliers receive the same payment under Medicare for these wheelchairs as would otherwise apply, but may bill beneficiaries for any difference between the payment and the actual charge for the wheelchair. The CMS may require suppliers to inform beneficiaries of their potential financial liability in these cases.
Congressional Research Service · summary of “Introduced in Senate” version · Jan 24, 2025
Who lobbies on it
3 organizations, more than 83% of Senate bills · 26 filings · Q1 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
American Association for Homecare (aahomecare)
7 of 7 quarters
“…Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.”
$1.2M lobbying spend in 2026 to date, all issuesQ3 2026 filing
-
Everytown for Gun Safety Action Fund
4 of 7 quarters
“Policy issues related to gun crime and public safety H.R. 3115 / S. 1531 - Assault Weapons Ban of 2025 H.R. 38 / S. 214 - Concealed Carry Reciprocity Act H.R. 2618 / S. 1294 - Federal Firearm Licensee Act H.R. 18 - Bipartisan Background Checks H.R. 768 / S. 247 - Extreme Risk Protection Order Expansion Act H.R. 1987…”
$2.0M lobbying spend in 2026 to date, all issuesQ2 2026 filing
-
Medline
1 of 7 quarters
“Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406)…”
$1.3M lobbying spend in 2026 to date, all issuesQ2 2026 filing
Organizations that named S. 247 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Jan 24, 2025Read twice and referred to the Committee on Finance.
- Jan 24, 2025Introduced in Senate